Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Tob Regul Sci. 2021 May;7(3):177–183. doi: 10.18001/trs.7.3.3

Table 2.

Study 2: Mean (SD) and Median Particulate Matter (PM2.5μg/m3) for Each Study Condition.

Pre-ECIG Use During ECIG Use
Condition Mean (SD) Median Mean (SD) Median
15 W 0 mg/ml 2.22 (1.35) 1.75 22.39 (55.70) 1.97
15 W 3 mg/ml 2.64 (3.89) 1.30 23.99 (63.14) 4.35
15 W 6 mg/ml 2.91 (1.16) 3.19 6.39 (7.83) 4.05
45 W 0 mg/ml 1.60 (0.84) 1.75 181.78 (311.96) *+ 61.07
45 W 3 mg/ml 2.57 (1.27) 2.52 46.13 (75.39)* 6.29
45 W 6 mg/ml 4.31 (5.39) 2.85 93.36 (164.01)*+ 13.47

30 minutes prior to the first 10-puff directed bout.

5 minutes during the 10-puff bout.

*

indicates difference from pre-ECIG use

+

indicates difference from 15 W with the same liquid concentration (only tested during ECIG use).